• Search
    • Menu

    Discovery Stems From Here

    Find your tools for building human cell-based models & screening assays

    Sensory Neuron MATURATION MAXIMIZER Kits now available

    Featured Product

    Microglia

    Human iPSC-derived Microglia provide a reliable and consistent model that phenotypically recapitulates human microglia responses in vitro.

    Featured Service

    Cell Reprogramming

    A complete suite of custom cell reprogramming and characterization services from dedicated specialists to generate iPSCs from human cells using cutting edge technologies.

    Featured White Paper

    Atrial Cardiomyocytes

    Are you using non-human cell models for your cardiac research? Download our new white paper to find out why human iPSC-derived Atrial Cardiomyocytes could improve your data.

    Welcome to Axol Bioscience

    YOUR HUMAN CELL CULTURE SPECIALISTS

    We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.

    Products
    Blog
    Services
    Application
    Notes
    Publications
    Contact Us

    Latest News

    • Chief Operating Officer appointed at Axol Bioscience

      15 May 2019

      We are delighted to announce that Chris Kirton joins us as our Chief Operating Officer; a senior operations leader with over 15 years of drug development, commercial and operational management experience in both industry and academia. Chris joins us from a leading supplier in the biotech industry and takes up his leadership role at Axol, bringing with him his extensive operational experience at the highest levels, focusing Axol's position and supporting growth within the Human iPSC-Derived Stem Cell market.

    • Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models

      2 May 2019


    • Neuroimmunology Drug Development (NIDD) 2019

      27 March 2019

      ✓ Our Booth #760
      ✓ Our Workshop (find out more)
      ✓ Our Poster (find out more)

    • Axol Bioscience launch human iPSC-derived Microglia

      13 December 2018

      Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.

    • Good Cell Culture Practice in Toxicology Seminar

      16 October 2018

      Axol Bioscience is presenting at the two-day seminar hold by Evercyte and Altetox in Vienna, from 30-31 October. Book your ticket today.